Synthetic Data Generation in Hematology - Paving the Way for OMOP and FHIR Integration.
Stud Health Technol Inform
; 316: 1472-1476, 2024 Aug 22.
Article
in En
| MEDLINE
| ID: mdl-39176482
ABSTRACT
This study advances the utility of synthetic study data in hematology, particularly for Acute Myeloid Leukemia (AML), by facilitating its integration into healthcare systems and research platforms through standardization into the Observational Medical Outcomes Partnership (OMOP) and Fast Healthcare Interoperability Resources (FHIR) formats. In our previous work, we addressed the need for high-quality patient data and used CTAB-GAN+ and Normalizing Flow (NFlow) to synthesize data from 1606 patients across four multicenter AML clinical trials. We published the generated synthetic cohorts, that accurately replicate the distributions of key demographic, laboratory, molecular, and cytogenetic variables, alongside patient outcomes, demonstrating high fidelity and usability. The conversion to the OMOP format opens avenues for comparative observational multi-center research by enabling seamless combination with related OMOP datasets, thereby broadening the scope of AML research. Similarly, standardization into FHIR facilitates further developments of applications, e.g. via the SMART-on-FHIR platform, offering realistic test data. This effort aims to foster a more collaborative research environment and facilitate the development of innovative tools and applications in AML care and research.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
Limits:
Humans
Language:
En
Journal:
Stud Health Technol Inform
Journal subject:
INFORMATICA MEDICA
/
PESQUISA EM SERVICOS DE SAUDE
Year:
2024
Document type:
Article
Affiliation country: